Choueiri and Motzer Chat on CheckMate-9ER and Other RCC Research

Season 4 Episode 46  ·  Apr 05, 2021, 04:48 PM

Headliner
Share
Subscribe

In our exclusive interview, Dr. Choueiri and Dr. Motzer discuss the clinical implications of the phase 3 CheckMate-9ER trial in advanced renal cell carcinoma and how to best use the combination in practice.

Share
Subscribe
Next
FDA Approval Insights: Trilaciclib in Extensive-Stage Small Cell Lung Cancer
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air